JP Morgan Chase’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $76.4M | Sell |
358,500
-118,300
| -25% | -$26.2M | ﹤0.01% | 1122 |
|
|
2025
Q4 | $109M | Buy |
476,800
+209,700
| +79% | +$47.8M | 0.01% | 905 |
|
|
2025
Q3 | $61.8M | Sell |
267,100
-63,700
| -19% | -$13M | ﹤0.01% | 1278 |
|
|
2025
Q2 | $61.4M | Sell |
330,800
-14,200
| -4% | -$2.64M | ﹤0.01% | 1205 |
|
|
2025
Q1 | $72.3M | Sell |
345,000
-338,100
| -49% | -$65.7M | 0.01% | 1097 |
|
|
2024
Q4 | $121M | Buy |
683,100
+379,500
| +125% | +$69.8M | 0.01% | 845 |
|
|
2024
Q3 | $60M | Buy |
303,600
+145,400
| +92% | +$27.1M | ﹤0.01% | 1214 |
|
|
2024
Q2 | $27.1M | Buy |
158,200
+67,600
| +75% | +$11.2M | ﹤0.01% | 1634 |
|
|
2024
Q1 | $16.5M | Sell |
90,600
-162,800
| -64% | -$28.1M | ﹤0.01% | 2042 |
|
|
2023
Q4 | $39.3M | Buy |
253,400
+217,200
| +600% | +$31.7M | ﹤0.01% | 1359 |
|
|
2023
Q3 | $5.4M | Buy |
36,200
+4,700
| +15% | +$690K | ﹤0.01% | 2778 |
|
|
2023
Q2 | $4.24M | Sell |
31,500
-226,500
| -88% | -$33.2M | ﹤0.01% | 2997 |
|
|
2023
Q1 | $41.1M | Sell |
258,000
-33,400
| -11% | -$5.11M | 0.01% | 1196 |
|
|
2022
Q4 | $47.1M | Buy |
291,400
+78,900
| +37% | +$12.1M | 0.01% | 1149 |
|
|
2022
Q3 | $28.5M | Sell |
212,500
-27,100
| -11% | -$3.89M | ﹤0.01% | 1344 |
|
|
2022
Q2 | $36.7M | Sell |
239,600
-131,700
| -35% | -$20.1M | 0.01% | 1205 |
|
|
2022
Q1 | $60.2M | Buy |
371,300
+78,400
| +27% | +$11.4M | 0.01% | 1072 |
|
|
2021
Q4 | $39.7M | Sell |
292,900
-572,000
| -66% | -$67.6M | ﹤0.01% | 1335 |
|
|
2021
Q3 | $93.3M | Buy |
864,900
+476,700
| +123% | +$54.5M | 0.01% | 902 |
|
|
2021
Q2 | $43.7M | Buy |
388,200
+280,500
| +260% | +$31.6M | 0.01% | 1283 |
|
|
2021
Q1 | $11.7M | Sell |
107,700
-1,141,600
| -91% | -$122M | ﹤0.01% | 2223 |
|
|
2020
Q4 | $134M | Buy |
1,249,300
+918,300
| +277% | +$88.2M | 0.02% | 670 |
|
|
2020
Q3 | $28.8M | Buy |
331,000
+140,200
| +73% | +$13.2M | ﹤0.01% | 1267 |
|
|
2020
Q2 | $18.7M | Sell |
190,800
-33,000
| -15% | -$2.91M | ﹤0.01% | 1409 |
|
|
2020
Q1 | $17.1M | Buy |
223,800
+62,400
| +39% | +$5.32M | ﹤0.01% | 1359 |
|
|
2019
Q4 | $14.3M | Buy |
161,400
+6,400
| +4% | +$531K | ﹤0.01% | 1829 |
|
|
2019
Q3 | $11.7M | Sell |
155,000
-501,000
| -76% | -$34.3M | ﹤0.01% | 1998 |
|
|
2019
Q2 | $45.9M | Buy |
656,000
+489,500
| +294% | +$38.5M | 0.01% | 1016 |
|
|
2019
Q1 | $13.4M | Sell |
166,500
-174,600
| -51% | -$14.3M | ﹤0.01% | 1812 |
|
|
2018
Q4 | $31.4M | Buy |
341,100
+280,900
| +467% | +$24.7M | 0.01% | 1159 |
|
|
2018
Q3 | $5.69M | Sell |
60,200
-39,000
| -39% | -$3.7M | ﹤0.01% | 2639 |
|
|
2018
Q2 | $9.19M | Buy |
+99,200
| New | +$9.69M | ﹤0.01% | 2211 |
|
|
2018
Q1 | – | Sell |
-159,100
| Closed | -$15.4M | – | 5351 |
|
|
2017
Q4 | $15.4M | Buy |
159,100
+25,200
| +19% | +$2.37M | ﹤0.01% | 1778 |
|
|
2017
Q3 | $11.9M | Hold |
133,900
| – | – | ﹤0.01% | 1855 |
|
|
2017
Q2 | $9.71M | Sell |
133,900
-133,600
| -50% | -$8.98M | ﹤0.01% | 1995 |
|
|
2017
Q1 | $17.4M | Sell |
267,500
-360,300
| -57% | -$22.7M | ﹤0.01% | 1552 |
|
|
2016
Q4 | $39.3M | Buy |
627,800
+620,428
| +8,416% | +$37.9M | 0.01% | 1041 |
|
|
2016
Q3 | $465K | Sell |
7,372
-3,215,825
| -100% | -$208M | ﹤0.01% | 3425 |
|
|
2016
Q2 | $200M | Buy |
3,223,197
+2,878,282
| +834% | +$175M | 0.05% | 365 |
|
|
2016
Q1 | $19.7M | Sell |
344,915
-94,685
| -22% | -$5.28M | 0.01% | 1349 |
|
|
2015
Q4 | $26M | Buy |
439,600
+335,000
| +320% | +$19.3M | 0.01% | 1159 |
|
|
2015
Q3 | $5.69M | Buy |
104,600
+74,700
| +250% | +$4.86M | ﹤0.01% | 2141 |
|
|
2015
Q2 | $2.01M | Buy |
+29,900
| New | +$1.95M | ﹤0.01% | 2912 |
|
|
2015
Q1 | – | Sell |
-593,600
| Closed | -$38.8M | – | 4039 |
|
|
2014
Q4 | $38.8M | Sell |
593,600
-3,259,700
| -85% | -$206M | 0.01% | 1066 |
|
|
2014
Q3 | $223M | Buy |
+3,853,300
| New | +$214M | 0.05% | 382 |
|
|
2013
Q4 | – | Sell |
-36,128
| Closed | -$1.62M | – | 4071 |
|
|
2013
Q3 | $1.62M | Hold |
36,128
| – | – | ﹤0.01% | 2948 |
|
|
2013
Q2 | $1.49M | Buy |
+36,128
| New | +$1.58M | ﹤0.01% | 3005 |
|
Other funds holding ABBV
VCM
VPM
JP Morgan Chase's ABBV Position: Q1 2026 in Review
JP Morgan Chase increased its AbbVie (ABBV) stake by 8.3% in Q1 2026, buying an estimated $965M and bringing the position to 56,741,691 shares worth $12.1B. The position accounts for 0.78% of the portfolio, ranked #19.
JP Morgan Chase first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $13.1B in Q3 2025. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- JP Morgan Chase held 56,741,691 shares of AbbVie worth $12.1B as of Q1 2026.
- JP Morgan Chase bought 4,348,368 AbbVie shares in Q1 2026, an estimated $965M.
- AbbVie made up 0.78% of JP Morgan Chase's portfolio in Q1 2026, its #19 holding.
- JP Morgan Chase first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
- JP Morgan Chase's AbbVie position peaked at $13.1B in Q3 2025.
- 4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.